Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL MEDICAL DEVICE ENGINEERING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL MEDICAL DEVICE ENGINEERING MARKETSIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL MEDICAL DEVICE ENGINEERING MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6. INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7. INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8. COST ANALYSIS BREAKDOWN
9. TECHNONLOGY ROADMAP
10. INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11. REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12. REIMBURSEMENT FRAMEWORK
13. OPPUTUNITY MAP ANALYSIS
14. VALUE CHAIN ANALYSIS
15. HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.10 ECONOMIC DEVELOPMENT
16. GLOBAL MEDICAL DEVICE ENGINEERING MARKET, BY SERVICE TYPE
16.1 OVERVIEW
16.2 PRODUCT DESIGN & DEVELOPMENT
16.2.1 CONCEPTUALIZATION & IDEATION
16.2.2 INDUSTRIAL & MECHANICAL DESIGN
16.2.3 USER-CENTERED DESIGN (UCD) & ERGONOMICS
16.2.4 MATERIALS & COMPONENT SELECTION
16.2.5 FINITE ELEMENT ANALYSIS (FEA) & SIMULATION
16.2.6 DESIGN FOR MANUFACTURING (DFM)
16.3 PROTOTYPING & TESTING
16.3.1 RAPID PROTOTYPING (3D PRINTING, CNC, INJECTION MOLDING)
16.3.2 MECHANICAL, ELECTRICAL & THERMAL TESTING
16.3.3 PRECLINICAL TESTING & VALIDATION
16.3.4 BIOCOMPATIBILITY & TOXICITY TESTING
16.3.5 FAILURE MODE & EFFECTS ANALYSIS (FMEA)
16.4 MANUFACTURING & SUPPLY CHAIN MANAGEMENT
16.4.1 CONTRACT MANUFACTURING (OEM & ODM)
16.4.2 COMPONENT SOURCING & SUPPLY CHAIN OPTIMIZATION
16.4.3 CLEANROOM & STERILE MANUFACTURING
16.4.4 LEAN MANUFACTURING & SIX SIGMA PRACTICES
16.4.5 QUALITY CONTROL & ASSURANCE (ISO 13485, GMP)
16.5 REGULATORY COMPLIANCE & CONSULTING
16.5.1 RISK MANAGEMENT & SAFETY ASSESSMENTS
16.5.2 CLINICAL & REGULATORY STRATEGY CONSULTING
16.5.3 REGULATORY SUBMISSIONS (FDA, CE MARKING, ISO CERTIFICATION)
16.5.4 POST-MARKET SURVEILLANCE & COMPLIANCE AUDITS
16.5.5 LEGAL & ETHICAL CONSIDERATIONS
16.6 EMBEDDED SYSTEMS & SOFTWARE DEVELOPMENT
16.7 OTHER
17. GLOBAL MEDICAL DEVICE ENGINEERING MARKET, BY DEVICE TYPE
17.1 OVERVIEW
(NOTE: MARKET VALUE, VOLUME AND ASP ANALYSIS WOULD BE PROVIDED FOR ALL SEGMENTS AND SUB-SEGMENTS OF PRODUCT)
17.2 DIAGNOSTIC DEVICES
17.2.1 IMAGING SYSTEMS
17.2.1.1. MAGNETIC RESONANCE IMAGING (MRI)
17.2.1.1.1. OPEN MRI
17.2.1.1.2. CLOSED MRI
17.2.1.2. COMPUTED TOMOGRAPHY (CT) SCANNERS
17.2.1.2.1. LOW-SLICE CT (1-16 SLICES)
17.2.1.2.2. MID-SLICE CT (32-64 SLICES)
17.2.1.2.3. HIGH-SLICE CT (128+ SLICES)
17.2.1.2.4. CONE BEAM CT (CBCT)
17.2.1.2.5. SPECTRAL CT
17.2.1.3. ULTRASOUND DEVICES
17.2.1.3.1. 2D ULTRASOUND
17.2.1.3.2. 3D/4D ULTRASOUND
17.2.1.3.3. DOPPLER ULTRASOUND
17.2.1.3.4. PORTABLE & HANDHELD ULTRASOUND
17.2.1.3.5. HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU)
17.2.1.4. X-RAY SYSTEMS
17.2.1.4.1. ANALOG X-RAY
17.2.1.4.2. DIGITAL RADIOGRAPHY (DR)
17.2.1.4.3. COMPUTED RADIOGRAPHY (CR)
17.2.1.4.4. FLUOROSCOPY SYSTEMS
17.2.1.5. POSITRON EMISSION TOMOGRAPHY (PET) SCANNERS
17.2.1.5.1. PET-CT SYSTEMS
17.2.1.5.2. PET-MRI SYSTEMS
17.2.1.5.3. STANDALONE PET SCANNERS
17.2.2 IN-VITRO DIAGNOSTIC (IVD) EQUIPMENT
17.2.2.1. MOLECULAR DIAGNOSTICS
17.2.2.1.1. POLYMERASE CHAIN REACTION (PCR)
17.2.2.1.2. NEXT-GENERATION SEQUENCING (NGS)
17.2.2.1.3. DNA MICROARRAYS
17.2.2.1.4. ISOTHERMAL NUCLEIC ACID AMPLIFICATION
17.2.2.2. IMMUNOASSAYS
17.2.2.2.1. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
17.2.2.2.2. CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
17.2.2.2.3. RADIOIMMUNOASSAY (RIA)
17.2.2.3. HEMATOLOGY ANALYZERS
17.2.2.3.1. 3-PART HEMATOLOGY ANALYZERS
17.2.2.3.2. 5-PART HEMATOLOGY ANALYZERS
17.2.2.3.3. POINT-OF-CARE HEMATOLOGY DEVICES
17.2.2.4. POINT-OF-CARE TESTING DEVICES
17.2.2.4.1. GLUCOSE MONITORING SYSTEMS
17.2.2.4.2. RAPID ANTIGEN/ANTIBODY TESTS
17.2.2.4.3. HOME PREGNANCY & FERTILITY KITS
17.2.2.4.4. INFECTIOUS DISEASE RAPID TESTS
17.3 THERAPEUTIC DEVICES
17.3.1 SURGICAL INSTRUMENTS & ROBOTICS
17.3.1.1. MINIMALLY INVASIVE SURGERY (MIS) DEVICES
17.3.1.1.1. LAPAROSCOPIC INSTRUMENTS
17.3.1.1.2. ENDOSCOPIC INSTRUMENTS
17.3.1.1.3. ARTHROSCOPIC DEVICES
17.3.1.1.4. ROBOTIC-ASSISTED MIS SYSTEMS
17.3.1.2. ROBOT-ASSISTED SURGERY (RAS) SYSTEMS
17.3.1.2.1. ORTHOPEDIC SURGERY ROBOTS
17.3.1.2.2. NEUROSURGERY ROBOTS
17.3.1.2.3. UROLOGY & GYNECOLOGY SURGERY ROBOTS
17.3.2 IMPLANTABLE MEDICAL DEVICES
17.3.2.1. ORTHOPEDIC IMPLANTS
17.3.2.1.1. HIP IMPLANTS
17.3.2.1.2. KNEE IMPLANTS
17.3.2.1.3. SPINAL IMPLANTS
17.3.2.1.4. TRAUMA FIXATION DEVICES
17.3.2.2. CARDIOVASCULAR IMPLANTS
17.3.2.2.1. PACEMAKERS
17.3.2.2.2. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)
17.3.2.2.3. HEART VALVES
17.3.2.2.4. CORONARY & PERIPHERAL STENTS
17.3.2.3. NEUROSTIMULATION DEVICES
17.3.2.3.1. DEEP BRAIN STIMULATORS (DBS)
17.3.2.3.2. SPINAL CORD STIMULATORS (SCS)
17.3.2.3.3. VAGUS NERVE STIMULATORS (VNS)
17.3.2.3.4. SACRAL NERVE STIMULATORS
17.3.2.4. COCHLEAR & AUDITORY IMPLANTS
17.3.2.4.1. COCHLEAR IMPLANTS
17.3.2.4.2. BONE-ANCHORED HEARING AIDS (BAHA)
17.3.3 DRUG DELIVERY SYSTEMS
17.3.3.1. SMART INFUSION PUMPS
17.3.3.1.1. LARGE VOLUME PUMPS (LVP)
17.3.3.1.2. SYRINGE INFUSION PUMPS
17.3.3.1.3. PATIENT-CONTROLLED ANALGESIA (PCA) PUMPS
17.3.3.1.4. INSULIN PUMPS
17.3.3.2. SMART INHALERS
17.3.3.2.1. METERED-DOSE INHALERS (MDIS)
17.3.3.2.2. DRY POWDER INHALERS (DPIS)
17.3.3.2.3. NEBULIZERS
17.4 PATIENT MONITORING DEVICES
17.4.1 WEARABLE MEDICAL DEVICES
17.4.1.1. SMARTWATCHES & FITNESS TRACKERS
17.4.1.1.1. HEART RATE MONITORING
17.4.1.1.2. BLOOD OXYGEN (SPO2) MONITORING
17.4.1.1.3. ECG MONITORING
17.4.1.2. CONTINUOUS GLUCOSE MONITORS (CGM)
17.4.1.2.1. REAL-TIME CGM (RTCGM)
17.4.1.2.2. INTERMITTENTLY SCANNED CGM (ISCGM)
17.4.2 REMOTE PATIENT MONITORING (RPM) SYSTEMS
17.4.2.1. CARDIAC MONITORING DEVICES
17.4.2.1.1. HOLTER MONITORS
17.4.2.1.2. IMPLANTABLE LOOP RECORDERS
17.4.2.1.3. WIRELESS ECG
17.4.2.2. RESPIRATORY MONITORING DEVICES
17.4.2.2.1. PULSE OXIMETERS
17.4.2.2.2. CAPNOGRAPHY SYSTEMS
17.4.2.3. NEUROLOGICAL MONITORING DEVICES
17.4.2.3.1. EEG MONITORS
17.4.2.3.2. ELECTROMYOGRAPHY (EMG) DEVICES
17.5 HEALTHCARE IT & DIGITAL HEALTH SOLUTIONS
17.5.1 TELEMEDICINE PLATFORMS
17.5.1.1. VIDEO CONSULTATION PLATFORMS
17.5.1.1.1. GENERAL TELECONSULTATION
17.5.1.1.2. TELEPSYCHIATRY
17.5.1.1.3. TELEDERMATOLOGY
17.5.1.1.4. TELENEUROLOGY
17.5.1.2. REMOTE PATIENT MANAGEMENT SYSTEMS
17.5.1.2.1. MOBILE HEALTH APPS
17.5.1.2.2. AI-BASED SYMPTOM CHECKERS
17.5.2 ELECTRONIC HEALTH RECORDS (EHR)
17.5.2.1. CLOUD-BASED EHR
17.5.2.2. ON-PREMISE EHR
17.5.2.3. AI-DRIVEN EHR SYSTEMS
17.5.3 AI-BASED DIAGNOSTIC & DECISION-SUPPORT TOOLS
17.5.3.1. AI IN RADIOLOGY & IMAGING
17.5.3.2. AI IN PATHOLOGY
17.5.3.3. AI FOR HISTOPATHOLOGICAL IMAGE ANALYSIS
17.5.3.4. AUTOMATED CYTOLOGY ANALYSIS
17.6 OTHERS
18. GLOBAL MEDICAL DEVICE ENGINEERING MARKET, BY APPLICATION
18.1 OVERVIEW
18.2 CARDIOVASCULAR
18.3 ORTHOPEDICS
18.4 NEUROLOGY
18.5 ONCOLOGY
18.6 RESPIRATORY
18.7 GENERAL SURGERY
18.8 OPHTHALMOLOGY
18.9 DENTAL
18.10 OTHERS
19. GLOBAL MEDICAL DEVICE ENGINEERING MARKET, BY END USER
19.1 OVERVIEW
19.2 MEDICAL DEVICE MANUFACTURERS
19.3 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS)
19.4 HOSPITALS & HEALTHCARE PROVIDERS
19.5 REMOTE PATIENT MONITORING PROVIDERS
19.6 REGULATORY & COMPLIANCE BODIES
19.7 OTHERS
20. GLOBAL MEDICAL DEVICE ENGINEERING MARKET, BY COUNTRY
GLOBAL MEDICAL DEVICE ENGINEERING MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
20.1 NORTH AMERICA
20.1.1 U.S.
20.1.2 CANADA
20.1.3 MEXICO
20.2 EUROPE
20.2.1 GERMANY
20.2.2 U.K.
20.2.3 ITALY
20.2.4 FRANCE
20.2.5 SPAIN
20.2.6 RUSSIA
20.2.7 SWITZERLAND
20.2.8 TURKEY
20.2.9 BELGIUM
20.2.10 NETHERLANDS
20.2.11 DENMARK
20.2.12 SWEDEN
20.2.13 POLAND
20.2.14 NORWAY
20.2.15 FINLAND
20.2.16 REST OF EUROPE
20.3 ASIA-PACIFIC
20.3.1 JAPAN
20.3.2 CHINA
20.3.3 SOUTH KOREA
20.3.4 INDIA
20.3.5 SINGAPORE
20.3.6 THAILAND
20.3.7 INDONESIA
20.3.8 MALAYSIA
20.3.9 PHILIPPINES
20.3.10 AUSTRALIA
20.3.11 NEW ZEALAND
20.3.12 VIETNAM
20.3.13 TAIWAN
20.3.14 REST OF ASIA-PACIFIC
20.4 SOUTH AMERICA
20.4.1 BRAZIL
20.4.2 ARGENTINA
20.4.3 REST OF SOUTH AMERICA
20.5 MIDDLE EAST AND AFRICA
20.5.1 SOUTH AFRICA
20.5.2 EGYPT
20.5.3 BAHRAIN
20.5.4 UNITED ARAB EMIRATES
20.5.5 KUWAIT
20.5.6 OMAN
20.5.7 QATAR
20.5.8 SAUDI ARABIA
20.5.9 REST OF MEA
20.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
21. GLOBAL MEDICAL DEVICE ENGINEERING MARKET, SWOT AND DBMR ANALYSIS
22. GLOBAL MEDICAL DEVICE ENGINEERING MARKET, COMPANY PROFILE
22.1 3M HEALTH CARE
22.1.1 COMPANY OVERVIEW
22.1.2 REVENUE ANALYSIS
22.1.3 GEOGRAPHIC PRESENCE
22.1.4 PRODUCT PORTFOLIO
22.1.5 RECENT DEVELOPMENTS
22.2 ABBOTT LABORATORIES
22.2.1 COMPANY OVERVIEW
22.2.2 REVENUE ANALYSIS
22.2.3 GEOGRAPHIC PRESENCE
22.2.4 PRODUCT PORTFOLIO
22.2.5 RECENT DEVELOPMENTS
22.3 BAXTER INTERNATIONAL
22.3.1 COMPANY OVERVIEW
22.3.2 REVENUE ANALYSIS
22.3.3 GEOGRAPHIC PRESENCE
22.3.4 PRODUCT PORTFOLIO
22.3.5 RECENT DEVELOPMENTS
22.4 BECTON DICKINSON COMPANY
22.4.1 COMPANY OVERVIEW
22.4.2 REVENUE ANALYSIS
22.4.3 GEOGRAPHIC PRESENCE
22.4.4 PRODUCT PORTFOLIO
22.4.5 RECENT DEVELOPMENTS
22.5 BOSTON SCIENTIFIC CORPORATION
22.5.1 COMPANY OVERVIEW
22.5.2 REVENUE ANALYSIS
22.5.3 GEOGRAPHIC PRESENCE
22.5.4 PRODUCT PORTFOLIO
22.5.5 RECENT DEVELOPMENTS
22.6 CANON MEDICAL SYSTEMS CORPORATION
22.6.1 COMPANY OVERVIEW
22.6.2 REVENUE ANALYSIS
22.6.3 GEOGRAPHIC PRESENCE
22.6.4 PRODUCT PORTFOLIO
22.6.5 RECENT DEVELOPMENTS
22.7 CARDINAL HEALTH
22.7.1 COMPANY OVERVIEW
22.7.2 REVENUE ANALYSIS
22.7.3 GEOGRAPHIC PRESENCE
22.7.4 PRODUCT PORTFOLIO
22.7.5 RECENT DEVELOPMENTS
22.8 DANAHER CORPORATION
22.8.1 COMPANY OVERVIEW
22.8.2 REVENUE ANALYSIS
22.8.3 GEOGRAPHIC PRESENCE
22.8.4 PRODUCT PORTFOLIO
22.8.5 RECENT DEVELOPMENTS
22.9 FRESENIUS MEDICAL CARE
22.9.1 COMPANY OVERVIEW
22.9.2 REVENUE ANALYSIS
22.9.3 GEOGRAPHIC PRESENCE
22.9.4 PRODUCT PORTFOLIO
22.9.5 RECENT DEVELOPMENTS
22.10 GE HEALTHCARE
22.10.1 COMPANY OVERVIEW
22.10.2 REVENUE ANALYSIS
22.10.3 GEOGRAPHIC PRESENCE
22.10.4 PRODUCT PORTFOLIO
22.10.5 RECENT DEVELOPMENTS
22.11 HOLOGIC, INC.
22.11.1 COMPANY OVERVIEW
22.11.2 REVENUE ANALYSIS
22.11.3 GEOGRAPHIC PRESENCE
22.11.4 PRODUCT PORTFOLIO
22.11.5 RECENT DEVELOPMENTS
22.12 INTUITIVE SURGICAL
22.12.1 COMPANY OVERVIEW
22.12.2 REVENUE ANALYSIS
22.12.3 GEOGRAPHIC PRESENCE
22.12.4 PRODUCT PORTFOLIO
22.12.5 RECENT DEVELOPMENTS
22.13 JOHNSON & JOHNSON
22.13.1 COMPANY OVERVIEW
22.13.2 REVENUE ANALYSIS
22.13.3 GEOGRAPHIC PRESENCE
22.13.4 PRODUCT PORTFOLIO
22.13.5 RECENT DEVELOPMENTS
22.14 MEDTRONIC PLC
22.14.1 COMPANY OVERVIEW
22.14.2 REVENUE ANALYSIS
22.14.3 GEOGRAPHIC PRESENCE
22.14.4 PRODUCT PORTFOLIO
22.14.5 RECENT DEVELOPMENTS
22.15 PHILIPS HEALTHCARE
22.15.1 COMPANY OVERVIEW
22.15.2 REVENUE ANALYSIS
22.15.3 GEOGRAPHIC PRESENCE
22.15.4 PRODUCT PORTFOLIO
22.15.5 RECENT DEVELOPMENTS
22.16 RESMED INC.
22.16.1 COMPANY OVERVIEW
22.16.2 REVENUE ANALYSIS
22.16.3 GEOGRAPHIC PRESENCE
22.16.4 PRODUCT PORTFOLIO
22.16.5 RECENT DEVELOPMENTS
22.17 ROCHE DIAGNOSTICS INTERNATIONAL LTD
22.17.1 COMPANY OVERVIEW
22.17.2 REVENUE ANALYSIS
22.17.3 GEOGRAPHIC PRESENCE
22.17.4 PRODUCT PORTFOLIO
22.17.5 RECENT DEVELOPMENTS
22.18 SIEMENS HEALTHINEERS AG
22.18.1 COMPANY OVERVIEW
22.18.2 REVENUE ANALYSIS
22.18.3 GEOGRAPHIC PRESENCE
22.18.4 PRODUCT PORTFOLIO
22.18.5 RECENT DEVELOPMENTS
22.19 SMITH & NEPHEW PLC.
22.19.1 COMPANY OVERVIEW
22.19.2 REVENUE ANALYSIS
22.19.3 GEOGRAPHIC PRESENCE
22.19.4 PRODUCT PORTFOLIO
22.19.5 RECENT DEVELOPMENTS
22.20 STRYKER CORPORATION
22.20.1 COMPANY OVERVIEW
22.20.2 REVENUE ANALYSIS
22.20.3 GEOGRAPHIC PRESENCE
22.20.4 PRODUCT PORTFOLIO
22.20.5 RECENT DEVELOPMENTS
22.21 TERUMO CORPORATION
22.21.1 COMPANY OVERVIEW
22.21.2 REVENUE ANALYSIS
22.21.3 GEOGRAPHIC PRESENCE
22.21.4 PRODUCT PORTFOLIO
22.21.5 RECENT DEVELOPMENTS
22.22 THERMO FISHER SCIENTIFIC, INC.
22.22.1 COMPANY OVERVIEW
22.22.2 REVENUE ANALYSIS
22.22.3 GEOGRAPHIC PRESENCE
22.22.4 PRODUCT PORTFOLIO
22.22.5 RECENT DEVELOPMENTS
22.23 ZIMMER BIOMET HOLDINGS, INC.
22.23.1 COMPANY OVERVIEW
22.23.2 REVENUE ANALYSIS
22.23.3 GEOGRAPHIC PRESENCE
22.23.4 PRODUCT PORTFOLIO
22.23.5 RECENT DEVELOPMENTS
22.24 FLEX HEALTH SOLUTIONS
22.24.1 COMPANY OVERVIEW
22.24.2 REVENUE ANALYSIS
22.24.3 GEOGRAPHIC PRESENCE
22.24.4 PRODUCT PORTFOLIO
22.24.5 RECENT DEVELOPMENTS
22.25 JABIL HEALTHCARE
22.25.1 COMPANY OVERVIEW
22.25.2 REVENUE ANALYSIS
22.25.3 GEOGRAPHIC PRESENCE
22.25.4 PRODUCT PORTFOLIO
22.25.5 RECENT DEVELOPMENTS
22.26 SANMINA CORPORATION
22.26.1 COMPANY OVERVIEW
22.26.2 REVENUE ANALYSIS
22.26.3 GEOGRAPHIC PRESENCE
22.26.4 PRODUCT PORTFOLIO
22.26.5 RECENT DEVELOPMENTS
22.27 CELESTICA HEALTHTECH
22.27.1 COMPANY OVERVIEW
22.27.2 REVENUE ANALYSIS
22.27.3 GEOGRAPHIC PRESENCE
22.27.4 PRODUCT PORTFOLIO
22.27.5 RECENT DEVELOPMENTS
22.28 INTEGER HOLDINGS CORPORATION
22.28.1 COMPANY OVERVIEW
22.28.2 REVENUE ANALYSIS
22.28.3 GEOGRAPHIC PRESENCE
22.28.4 PRODUCT PORTFOLIO
22.28.5 RECENT DEVELOPMENTS
RECENT DEVELOPMENTS NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST RELATED REPORTS
23. RELATED REPORTS
24. CONCLUSION
25. QUESTIONNAIRE
26. ABOUT DATA BRIDGE MARKET RESEARCH
